scholarly journals Portfolio Analysis of Research Grants in Data Science Funded by the National Heart, Lung, and Blood Institute

2019 ◽  
Vol 12 (12) ◽  
Author(s):  
Huiqing Li ◽  
Marissa Miller ◽  
Catherine Burke ◽  
Narasimhan Danthi ◽  
Marc Charette ◽  
...  
Keyword(s):  
Data Science ◽  
National Laboratory ◽  
Pacific Northwest National Laboratory ◽  
Science Research ◽  
Portfolio Analysis ◽  
Fiscal Year ◽  
Research Grants ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung

Leveraging emerging opportunities in data science to open new frontiers in heart, lung, blood, and sleep research is one of the major strategic objectives of the National Heart, Lung, and Blood Institute (NHLBI), one of the 27 Institutes/Centers within the National Institutes of Health (NIH). To assess NHLBI’s recent funding of research grants in data science and to identify its relative areas of focus within data science, a portfolio analysis from fiscal year 2008 to fiscal year 2017 was performed. In this portfolio analysis, an efficient and reliable methodology was used to identify data science research grants by utilizing several NIH databases and search technologies (iSearch, Query View Reporting system, and IN-SPIRE [Pacific Northwest National Laboratory, Richland, WA]). Six hundred thirty data science–focused extramural research grants supported by NHLBI were identified using keyword searches based primarily on NIH’s working definitions of bioinformatics and computational biology. Further analysis characterized the distribution of these grants among the heart, lung, blood, and sleep disease areas as well as the subtypes of data science projects funded by NHLBI. Information was also collected for data science research grants funded by other NIH institutes/centers using the same search and analysis methodology. The funding comparison among different NIH institutes/centers highlighted relative data science areas of emphasis and further identified opportunities for potential data science areas in which NHLBI could foster research advances.

scholarly journals Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute

2018 ◽  
Vol 50 (11) ◽  
pp. 982-987
Author(s):  
Christine Maric-Bilkan
Keyword(s):  
Science Research ◽  
Cardiovascular Complications ◽  
Portfolio Analysis ◽  
Future Research ◽  
Chronic Hypertension ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung ◽  
Future Research Directions ◽  
Funding Research

Chronic hypertension and preeclampsia are the most common complications of pregnancy. To clarify the contributions of the National Heart, Lung, and Blood Institute (NHLBI) to the field and identify potential research gaps, we performed portfolio analysis of awards related to preeclampsia and pregnancy-associated hypertension. A list of National Institutes of Health (NIH)-funded awards between fiscal years 2008-present was obtained through an NIH RePORTER search using the following terms: “preeclampsia” and “pregnancy-associated hypertension.” More in-depth analyses were performed on currently active awards supported by the NHLBI. The NHLBI is the lead institute at the NIH in funding research related to pregnancy-associated hypertension and second leading in funding research related to preeclampsia. The NHLBI currently supports 38 awards related to preeclampsia and six awards related to pregnancy-associated hypertension, with a combined total dollar investment of $21 million. Of the currently active, NHLBI-supported awards on preeclampsia and pregnancy-associated hypertension combined, 47% are related to basic science research, 30% to clinical, 14% to clinical trials, and 9% to early translational research. The focus of NHLBI-funded awards is primarily on vascular mechanisms and short and long-term cardiovascular complications of preeclampsia and pregnancy-associated hypertension. Despite steady funding for research on preeclampsia and pregnancy-associated hypertension, several gaps in knowledge exist. NHLBI held a workshop entitled Predicting, Preventing and Treating Preeclampsia to address some of these gaps and inform future research directions for the institute.

scholarly journals Notes from the Director, National Heart, Lung, and Blood Institute: transitions

Blood ◽  
2009 ◽  
Vol 113 (13) ◽  
pp. 2875-2877
Author(s):  
Elizabeth G. Nabel
Keyword(s):  
Federal Government ◽  
Early Stage ◽  
Strategic Plan ◽  
National Institutes Of Health ◽  
Fiscal Year ◽  
Blood Institute ◽  
National Heart ◽  
Grant Applications ◽  
National Heart Lung ◽  
New Policies

Abstract During this time of transition in the federal government and the National Institutes of Health, I write to assure the Blood community of the National Heart, Lung, and Blood Institute's (NHLBI) commitment to new and established investigators as outlined in the NHLBI Strategic Plan. This perspective discusses the NHLBI budget for the fiscal year 2009 and new policies for funding early stage investigators and revised grant applications.

scholarly journals Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities

Blood ◽  
2011 ◽  
Vol 118 (20) ◽  
pp. 5380-5382 ◽  
Author(s):  
Susan B. Shurin
Keyword(s):  
Early Stage ◽  
Advisory Council ◽  
Fiscal Year ◽  
Blood Institute ◽  
Resource Limitations ◽  
National Heart ◽  
National Heart Lung ◽  
Funding Mechanisms ◽  
Long Term Impact ◽  
First Time

Abstract Over the past 8 years, the National Institutes of Health (NIH) budget appropriation has lost purchasing power, with erosion of the benefits of the doubling of the budget less than a decade ago. For the first time in 40 years, the NIH appropriation in fiscal year 2011 was 1% less than in the previous year. The National Heart, Lung, and Blood Institute (NHLBI) has been closely managing its funds to protect its core functions: support and conduct of research, and training of biomedical research scientists. Rigorous evaluations of funding mechanisms, management of clinical studies, set-aside programs and funding guidelines are designed to help the Institute, in consultation with its advisory council, to minimize the long-term impact of extreme resource limitations on the advance and conduct of science. This report describes some recent actions taken by the NHLBI to maximize support for investigator-initiated research, maintain a balanced portfolio, and provide as much support as possible for established and early-stage investigators.

Sign in / Sign up

Export Citation Format

Share Document